Muscle dystrophy

April 14, 2019

Published by admin_auro at April 14, 2019

Categories

Embryo-derived peptide may aid in the treatment of regenerative muscle atrophy: Synthetic preimplantation factor (sPIF) increases the expression of IGF-1, PI3K(p85a) and B-Myb, decreases the expression of tumor suppressors, promotes regeneration of muscle cells, and reverses muscle atrophy via up regulation of its target gene, 14/April/2019, 3.25 pm

Introduction: What they say A study from the Cardiac Regeneration and Ageing Lab, School of Life Science, Shanghai University, Shanghai 200444, China shows that “miR-29b contributes […]

November 3, 2018

Published by admin_auro at November 3, 2018

Categories

Probiotic-based therapy for muscle atrophy and wasting: Probiotic Lactobacillus brevis OW38 increases the expression of FGF19 and its receptor ß-Klotho, phosphorylates ERK1/2 and S6K1, decreases the expression of tumor suppressors genes, promotes regeneration of muscle cells and hypertrophy of skeletal muscle, and reverses muscular atrophy and wasting via upregulation of its target gene, 3/October/2018, 11.08 am

Introduction: What they say A study from Department of Biology, University of Bergen, Bergen, Norway; and Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard […]

November 3, 2018

Published by admin_auro at November 3, 2018

Categories

A probiotic way to ameliorate muscle atrophy and wasting: Probiotic Lactobacillus pentosus var. plantarum C29 increases the expression of FGF19 and its receptor ß-Klotho, phosphorylates ERK1/2 and S6K1, decreases the expression of tumor suppressors genes, promotes regeneration of muscle cells and hypertrophy of skeletal muscle, and reverses muscular atrophy and wasting via upregulation of its target gene, 3/October/2018, 9.50 am

Introduction: What they say A study from Department of Biology, University of Bergen, Bergen, Norway; and Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard […]

August 29, 2018

Published by admin_auro at August 29, 2018

Categories

Reasanz(oning) to rescue muscle atrophy and wasting: Serelaxin (trade name: Reasanz), a recombinant relaxin-2 used in the treatment of acute heart failure, increases the expression of FGF19 and its receptor ß-Klotho, phosphorylates ERK1/2 and S6K1, decreases the expression of tumor suppressors genes, promotes regeneration of muscle cells and hypertrophy of skeletal muscle, and reverses muscular atrophy and wasting via upregulation of its target gene, 29/August/2018, 12.01 am

Introduction: What they say A study from Department of Biology, University of Bergen, Bergen, Norway; and Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard […]